Tag: Charles Ornstein
Will the improvements to the site be enough to ensure consumers can get coverage before the December 23 deadline?
With billions in potential savings for Medicare at stake, we asked drug experts and practitioners alike why more doctors don’t recommend generics when they can.
Four journalists describe how their own experiences with the health-care system has affected their reporting.
Two casualties of the transitioning American healthcare system.
What we know and don’t know about Obamacare’s effect on individual health insurance policies.
When taking prescription drugs, a lot is left unknown.
An Inspector General’s report faults Medicare for not tracking abuses in prescriptions.
A Nashville psychiatrist becomes the first physician to net $1 million in promotional-speaking fees from drug companies.
A veteran health reporter reflects on Medicare spending and family’s hospital decision-making.
Two conservative non-profits have poured $60 million into the presidential race, far outspending the super-PACS.